Objective: Since publication of the Respiratory Management of Acute Lung Injury and Acute Respiratory Distress Syndrome (ARMA) trial in 2000, use of tidal volume (V T ) less than or equal to 6 mL/kg predicted body weight with corresponding plateau airway pressures (P Plat ) less than or equal to 30 cm H 2 O has been advocated for acute lung injury. However, compliance with these recommendations is unknown. We therefore investigated V T (mL/kg predicted body weight) and P Plat (cm H 2 O) practices reported in studies of acute lung injury since ARMA using a systematic literature review (i.e., not a meta-analysis). Data Sources: PubMed, Scopus, and EMBASE. Study Selection: Randomized controlled trials and nonrandomized studies enrolling patients with acute lung injury from May 2000 to June 2013 and reporting V T . Data Extraction: Whether the study was a randomized controlled trial or a nonrandomized study and performed or not at an Acute Respiratory Distress Syndrome Network center; in randomized controlled trials, the pre-and postrandomization V T (mL/kg predicted body weight) and P Plat (cm H 2 O) and whether a V T protocol was used postrandomization; in nonrandomized studies, baseline V T and P Plat .
Data Synthesis: Twenty-two randomized controlled trials and 71 nonrandomized studies were included. Since 2000 at acute respiratory distress syndrome Network centers, routine V T was similar comparing randomized controlled trials and nonrandomized studies (p = 0.25) and unchanged over time (p = 0.75) with a mean value of 6.81 (95% CI, 6.45, 7.18) . At non-acute respiratory distress syndrome Network centers, routine V T was also similar when comparing randomized controlled trials and nonrandomized studies (p = 0.71), but decreased (p = 0.001); the most recent estimate for it was 6.77 (6.22, 7.32) . All V T estimates were significantly greater than 6 (p ≤ 0.02). In randomized controlled trials employing V T protocols, routine V T was reduced in both acute respiratory distress syndrome Network (n = 4) and non-acute respiratory distress syndrome Network (n = 11) trials (p ≤ 0.01 for both), but even postrandomization was greater than 6 (6.47 [6.29, 6 .65] and 6.80 [6.42, 7.17] , respectively; p ≤ 0.0001 for both). In 59 studies providing data, routine P Plat , averaged across acute respiratory distress syndrome Network or non-acute respiratory distress syndrome Network centers, was significantly less than 30 (p ≤ 0.02). Conclusions: For clinicians treating acute lung injury since 2000, achieving V T less than or equal to 6 mL/kg predicted body weight may not have been as attainable or important as P Plat less than or equal to 30 cm H 2 O. If so, there may be equipoise to test if V T less than or equal to 6 mL/kg predicted body weight are neces-(PBW) and plateau pressure (P Plat ) to less than or equal to 30 cm H 2 O significantly decreased mortality from 40% to 31% when compared with a protocol targeting a "traditional" control V T of 12 mL/kg PBW (see Appendix 1 for the methods used in patients randomized to the low tidal volume arm of the ARMA trial) (9) . Since the ARMA trial was published in 2000, this low V T (LV T ) protocol (10, 11) (also referred to as the "lung-protective ventilation protocol") (12) has been advocated by the ARDSNet (Appendix 2) as well as the Surviving Sepsis Campaign (SSC) Guidelines (13) , the Institute for Healthcare Improvement (14) , and the German Sepsis Society (15) . Adherence to mechanical ventilation with V T less than or equal to 6 mL/kg PBW has also been stipulated for use in RCTs testing new therapies for ALI and has even been recommended for mechanically ventilated patients without ALI (16, 17) .
Despite these recommendations, evidence suggests that physicians have not routinely maintained V T less than or equal to 6 mL/kg PBW in patients with ALI. Surveys in the United States (18) , Ireland (19) , Finland (20) , Mexico (21) , and Canada (22) over the past 10 years reported routine V T (±sd) in patients with ALI greater than 6 mL/kg PBW (7.0 ± 1.6, 8.4 ± 2.0, 8.6 ± 1.9, 8.3 ± 3.0, and 9.0 ± 2.5, respectively). Recently, published RCTs of ALI/ARDS from the United States and Europe beginning enrollment in 2006 also reported routine V T greater than or equal to 6 mL/kg PBW (7.3 ± 1.5 and 8.1 ± 1.8, respectively, averaged over study groups) (23, 24). However, routine P Plat in these studies was less than or equal to 30 cm H 2 O. We therefore hypothesized that since publication of the ARMA trial, although widely advocated, V T less than or equal to 6 mL/kg PBW have not routinely been used in patients. To test this hypothesis, we performed a systematic literature review (i.e., not a meta-analysis) and analyzed V T and accompanying P Plat used for ALI in RCTs and nonrandomized studies (NRSs) conducted since ARMA.
MATERIALS AND METHODS

Literature Search
PubMed, Scopus, and EMBASE databases were searched employing the search terms and strategy summarized in Appendix 3.
The search was limited to human subjects, the English language, and publication dates from May 2000 until June 2013. References from retrieved reports were examined for additional studies. Both RCTs and NRSs (i.e., observational studies or uncontrolled treatment studies) were analyzed if the patient population studied met diagnostic criteria for ALI (25); the date of initial enrollment followed publication of the ARMA trial (May 4, 2000) ; and the average routine V T for the population studied were reported. Two authors (D.S.J., P.Q.E.) independently reviewed all citations and abstracts followed by relevant full-text articles to determine study suitability. Disagreements were resolved by consensus. This study was reviewed by local institutional review board and was deemed exempt from approval.
Data Extraction
Extracted data from selected studies included the following: the number of enrolled patients; patient ages and sex; V T (in mL/kg PBW); P Plat ; risk factors for ALI; baseline Pao 2 :Fio 2 ratios; Acute Physiology and Chronic Health Evaluation II scores, Lung Injury scores, and Simplified Acute Physiology Score II; reported mortality rates; exclusion criteria; whether the trial took place at a single center or multiple centers; geographic location; location of the trial at either an ARD-SNet or non-ARDSNet center; and for RCTs, whether an LV T protocol based on the ARMA trial or similar criteria was employed following patient randomization. For RCTs, V T prerandomization and the first V T reported postrandomization (if available) were recorded, whereas for NRSs, the baseline V T was recorded. For studies providing data for individual patients, group mean values were calculated. Prerandomization and baseline V T and P Plat were considered routine ones. For studies in which V T was provided in mL/kg or total mL only, attempts were made to contact corresponding authors to obtain V T in mL/kg PBW. Tidal volumes based on ideal body weight (IBW) were considered comparable to ones based on PBW (9, (26) (27) (28) (29) (30) (31) (32) (33) (34) . If only V T in mL/kg total body weight was available, then a conversion factor was applied based on previous literature documenting a difference of +1.55 mL/kg between V T per PBW and V T per total body weight (20) . This conversion was necessary for one RCT and nine non-RCTs (35-44). For 56 studies providing V T in mL only, investigators from four subsequently provided it in mL/kg PBW or mL/kg IBW (29, 35, 39, 45) . Remaining studies were excluded.
Data Analysis
All analyses were done using R packages meta (http://www. cran.r-project.org/package=meta) and metafor (http://www. jstatsoft.org/v36/i03) unless stated otherwise. For studies with more than one group, V T and P Plat data were first combined to generate study-level summary statistics (26-28, 30, 31, [46] [47] [48] [49] [50] [51] . This was justified because there was little difference between treatment groups within each study. Random-effect metaanalysis and meta-regression were performed with inversevariance weighting and estimated using restricted maximum likelihood. Although these were the most appropriate methods for our analysis, this is not a standard meta-analysis since tidal volume is not the experimental treatment or outcome, and it is similar across treatment groups. The month and year of initial enrollment for studies were used for analysis. For two RCTs and six NRSs, only initial years of enrollment were available for analysis ( 43, [51] [52] [53] [54] [55] [56] . The 95% confidence bands were estimated and plotted. The change in V T (pre-vs postrandomization) was analyzed via a special bivariate meta-analysis random-effect model (57) using SAS version 9.3 (SAS Institute Inc., Cary, NC). Two-sided p values less than or equal to 0.05 were considered significant. individual studies (D.S.J., P.Q.E.) were in agreement that 93 of these studies met inclusion criteria ( Fig. 1 
RESULTS
Literature Search and Study Characteristics
Routine Tidal Volumes
We first examined the mean V T (mL/kg PBW) routinely prescribed for patients in four groups of studies: prerandomization in RCTs or at baseline in NRSs at ARDSNet (Fig. 2,  A and B , respectively) or non-ARDSNet centers (Fig. 2, C and D, respectively). The area of each circle in Figure 1 is proportional to the inverse of the variance associated with the mean V T value for each study. A weighted regression line with 95% CIs for the relationship over the study period (May 2000 to June 2013) between V T and date of initial study enrollment is shown for each of the four groups of trials. Baseline V T was not significantly associated with baseline Pao 2 :Fio 2 or P Plat (each p = not significant) ( Table E5 , Supplemental Digital Content 5, http://links.lww. com/CCM/A988 and Table E6 , Supplemental Digital Content 6, http://links.lww.com/ CCM/A989). Other baseline measures of disease severity were reported in fewer than 50% of studies and were not analyzed. Across the study period, routine mean V T was greater than 6 mL/kg PBW in 87 of the 93 studies analyzed. At ARDSNet centers, although the value of routinely prescribed V T decreased over the study period in a pattern that approached significance for RCTs (rate of annual change in V T [mL/kg PBW] [95% CI]: -0.07 [-0.14, 0.006], p = 0.07), routine V T did not change significantly in NRSs (0.06 [-0.40, 0.52], p = 0.81). At non-ARDSNet centers, routine V T did not change significantly in RCTs (-0.07 [-0.25, 0.10], p = 0.40) but did decrease significantly in NRSs (-0.14 [-0.22, -0.05], p = 0.002). Since changes in V T comparing RCTs versus NRSs at either ARDSNet or non-ARDSNet centers were not significantly different (p = 0.60 and 0.58, respectively), we calculated common slopes to increase the detection of significant reductions over time. After combining RCTs and NRSs, the mean annual V T change over the study period was still not significant for ARDSNet centers (-0.03 [-0.21, 0.15], p = 0.75) but was significant for non-ARDSNet centers (-0.13 [-0.20, -0.05], p = 0.001).
We then compared routine V T at ARDSNet and non-ARD-SNet centers to the widely recommended goal of 6 mL/kg PBW. At ARDSNet centers, where routine V T have not changed significantly over the study period, V T was significantly higher than 6 mL/kg PBW (6.81 [6.45, 7.18] , p ≤ 0.0001). Furthermore, at non-ARDSNet centers, where there have been significant decreases in V T over the study period, even the estimated mean V T (95% CI) at the time of the most recent study did not meet this goal and was significantly greater than 6 mL/kg PBW (6.77 [6.22, 7.32]; p = 0.006).
Changes in Tidal Volumes Following Randomization in RCTs
We next examined how V T changed from pre-to postrandomization in RCTs. Four of five ARDSNet and 11 of the 14 non-ARDSNet center RCTs reported postrandomization V T and also stipulated use of an LV T protocol during the postrandomization period ( (52, 60, 61, 72, 74) and five non-ARDSNet centers targeted a V T of 6-8 mL/kg PBW (62, 65, 68, 69, 75) . Figure 3 shows mean (±se) V T pre-and postrandomization for ARDSNet RCTs (Fig. 3A) and for non-ARDSNet RCTs that either did ( Fig. 3B) or did not (Fig.  3C) stipulate the use of an LV T protocol. In RCTs employing an LVT protocol, postrandomization V T increased over time at ARDSNet centers (slope: 0.04 [0.02, 0.07], p = 0.0003) but not at non-ARDSNet centers (slope: 0.01 [-0.15, 0.18], p = 0.86) (Fig. 2, E and F) . Across RCTs, mean (95% CI) changes in V T from pre-to postrandomization were highly significant for ARDSNet and non-ARD-SNet RCTs employing an LV T protocol (-0.67 [-1.206, -0.14], p = 0.01, and -0.66 [-0.96, -0.36], p < 0.0001, respectively) but not for non-ARDSNet trials not reporting using a protocol (0.03 [-0.56, 0.62], p = 0.91). Despite significant reductions in V T in RCTs stipulating an LV T protocol, the mean (95% CI) postrandomization V T at ARDSNet (6.47 [6.29, 6.65]) and non-ARDSNet (6.80 [6.42, 7.17] ) centers were still significantly greater than 6 mL/kg PBW over the study period (both p ≤ 0.0001). 
Routine Plateau Pressures
Eighteen RCTs and 41 NRSs reported P Plat . Figure 2 shows the routine mean P Plat in patients prerandomization in RCTs and at baseline in NRSs at ARDSNet (Fig. 4, A and B, respectively) and non-ARDSNet (Fig. 4, C and D, In RCTs that stipulated use of an LV T protocol, P Plat postrandomization decreased over the study period at ARDSNet (-0.31 [-0.55, -0.08], p = 0.009) but not at non-ARD-SNet centers (0.53 [-0.29, 1.34], p = 0.20) (Fig. 4, E and F) . Postrandomization mean P Plat was less than or equal to 30 cm H 2 O in all but two of these trials.
DISCUSSION
Since the ARMA trial, routine V T administered to patients with ALI at academic centers has decreased significantly at non-ARD-SNet but not at ARDSNet centers. However, when routine V T was either averaged over this time period for ARDSNet centers (mean [95% CI] mL/kg PBW: 6.81 [6.45, 7.18] ) or estimated at the time of the most recent RCTs or NSRs at non-ARDSNet centers (6.77 [6.22, 7 .32]), these remained 10-15% significantly greater than the 6 mL/kg PBW V T widely recommended based on the ARD-SNet LV T protocol (9) . Highlighting differences between actual and recommended practice, in RCTs at both ARDSNet and non-ARDSNet centers stipulating an LV T protocol postrandomization, enrolled patients on average have had their routine V T reduced significantly. However, even after these reductions, V T in these trials (6.47 [6.29, 6.65] and 6.80 [6.42, 7.17], respectively) remained significantly greater than 6 mL/kg PBW.
Failure to routinely employ the ARDSNet LV T and to achieve its stated V T goal has frequently been invoked as evidence that physicians do not effectively incorporate clinical research results and thereby potentially jeopardize patient care (114, 115) . In 2009, investigators at the University of Washington noted "…since the publication of the landmark randomized trial demonstrating the efficacy of lung-protective ventilation (LPV), a large proportion of patients with ALI still receive mechanical ventilation with tidal volumes above the goal of 6 mL/kg PBW. Barriers to the delivery of LPV include concern about adverse effects of low tidal volumes, inadequate knowledge of the LPV protocol, under-recognition of ALI, and an unwillingness of the bedside physician to relinquish control of the ventilator" (11) . However, there are alternative explanations for this discrepancy.
One explanation is that rather than targeting a specific V T level, physicians adjust V T based on airway pressures such as a P Plat less than or equal to 30 cm H 2 O (84, 116) . Titrating to such a P Plat does not always necessitate the level of V T recommended with the LV T protocol. In the absence of higher airway pressures, physicians may be more concerned about the potential adverse effects of lower V T (e.g., patient-ventilator dyssynchrony, hypercapnia, and hypoxemia) (12) . Analysis of physician practice including ARMA trial prerandomization data suggests that physicians have routinely adjusted V T based on airway pressures or measures of lung compliance (117) (118) (119) (120) . Notably, the widely advocated SSC sepsis bundles (121) (in contrast to the SSC guidelines) directed titration of V T to achieve a P Plat less than or equal to 30 cm H 2 O but did not recommend a specific V T level. This component of the bundles has been well adhered (122, 123) . Consistent with such practice, in the present study, although baseline V T was greater than those targeted in the ARDSNet LV T protocol, baseline P Plat was less than or equal to 30 cm H 2 O in the majority of studies.
Concerns regarding the design and interpretation of the ARMA trial may have also limited acceptance of the LV T protocol. At the trial's publication, questions were raised as to whether it had demonstrated benefit with low V T as opposed to introducing harm with the high "traditional" control V T of 12 mL/ kg PBW (124) . Postrandomization airway pressures (mean ± se) in these controls (34.1 ± 0.4 cm H 2 O) were greater than before randomization in these subjects (30.3 ± 0.6 cm H 2 O) as well as in control patients not having their V T raised after randomization in other V T trials (≤ 30 cm H 2 O) (120). Such differences have confounded meta-analyses of V T trials and prevented a definitive conclusion about the benefit of the ARDSNet LV T protocol (125) . By not including a control group in ARMA representing conventional therapy, the trial was unable to demonstrate that the LV T protocol improved survival compared to routine care (126) . A recent large observational study did report that adherence to the ARDSNet LV T protocol based on reductions in V T and P Plat alone or together was associated with reduced mortality in patients with ALI (127) . However, this study's observational design and use of both V T and P Plat to assess adherence to the ARDSNet protocol potentially complicate its interpretation.
In contrast to routine care, our findings suggest that application of LV T protocols is frequently stipulated in RCTs investigating new therapies for ALI and that their use was associated with patients receiving significantly lower V T after enrollment than before. On the one hand, these reductions suggest that the presence and use of LV T protocols may increase prescription of lower tidal volumes (128) . However, this discrepancy in V T use comparing pre-and postrandomization periods also raises concerns. First, administration of V T during the investigation of a new therapy that on average differs from routine ones may confound interpretation of that therapy's effects during later clinical use. Such discrepancies may have the greatest impact for new therapies related to ventilator management. For example, maneuvers to promote airway recruitment might result in greater improvements in oxygenation in the setting of lower V T , which increases the potential for atelectasis, compared to higher V T . The second concern relates to the potential for practice misalignments to develop (120). As noted above, several lines of evidence indicate that physicians routinely titrate V T based on airway pressures (e.g., P Plat ) and the underlying severity of lung injury as reflected by lung compliance. Patients with less severe lung injury and better lung compliance receive higher V T than patients with more severe disease and lower compliance. Prior analysis of the ARMA trial showed that randomizing patients into fixed treatment groups (i.e., low or high V T groups) disrupted this relationship between routinely applied V T and the severity of disease and created practice misalignments (120) . Stipulating use of the ARDSNet LV T protocol or a similar one in trials would introduce this same risk and further confound extrapolation of trial results clinically.
The findings that both routine V T and postenrollment ones in RCTs employing LV T protocols have remained greater than 6 mL/kg PBW raise the possibility that this widely advocated goal may be unachievable in many patients with ALI. Even at ARDSNet centers where routine adoption of LV T protocols might be most expected, routine and postenrollment V T did not change after ARMA and remained on average between 6.5 and 7.0 mL/kg PBW. Although V T has decreased over the past decade at non-ARDSNet centers, they started at higher levels (p = 0.01) than at ARDSNet centers and, based on the most recent estimates, remain significantly greater than 6 mL/kg PBW.
This study has limitations. First, although we extracted recorded prerandomization and baseline V T for both RCTs and NRSs, it is possible that with routine care, these may have decreased following admission and reached those targeted by the LV T protocol. However, such reductions have not occurred in other studies that examined use of the LV T protocol at later time points (128) . Second, inability of most ventilators to allow adjustment of V T in mL/kg PBW may have resulted in the application V T different from 6 mL/kg PBW for some patients in which this level was in fact intended. However, the fact that average V T was significantly greater than 6 mL/kg PBW for all comparisons made suggests that these differences were not related to obstacles arising from ventilator calibration alone. Third, in the present study, P Plat data were unavailable in several trials. It is possible that in these trials, P Plat was sufficiently greater than 30 cm H 2 O to raise concern regarding the routine V T that was being employed. However, mean P Plat was consistently less than or equal to 30 cm H 2 O in the majority of trials providing data. The absence of reported P Plat from some trials may also suggest that variables other than airway pressure were employed to manage V T . However, this absence does not necessarily mean that P Plat was not measured and employed by clinicians. Fourth, it is unclear why in ARDSNet RCTs postrandomization V T increased while P Plat decreased over time. Although a decrease in the severity of lung injury of patients postrandomization in these trials over time might explain this pattern, there was insufficient data to explore this. Finally, it is possible that our search strategy, which included English-language publications only, may have omitted relevant studies for analysis. However, the terminology we employed was broad and yielded more than 3,300 studies for review.
CONCLUSIONS
Minimizing injury related to mechanical ventilation during management of patients with ALI is important. However, more than a decade has passed since ARMA was published and adherence to the ARDSNet LV T protocol and application of V T of less than or equal to 6 mL/kg PBW are still not routine despite being advocated as the standard of care. Physicians do however routinely employ V T associated with P Plat less than or equal to 30 cm H 2 O. One interpretation of these findings is that clinicians caring for patients with ALI are more focused on limiting P Plat , and if P Plat is less than or equal to 30 cm H 2 O, they are less focused on limiting V T . Ultimately, studies employing mixed methods (e.g., surveys, focus groups, and cross-sectional audits of barriers/facilitators) may be needed to fully understand why V T less than or equal to 6 mL/kg PBW is not being employed by clinicians. However, if there is equipoise among clinicians regarding the need for V T less than or equal to 6 mL/kg PBW to improve the outcome of patients with ALI, but this strategy is being advocated for all cases, then a trial testing it is necessary. Such a trial would be needed not only to guide future care but also because a V T less than or equal to 6 mL/ kg PBW has not yet been compared to routine care. 
